ERBB2 and breast cancer: The multiCox model of the six core lncRNAs (AC010595.1, AC046168.1, AC069277.1, AP000904.1, LINC00528, and MIR762HG) had a high-level capability of risk assessment for HER2-positive breast cancer patients.